Hemetron raises €49K Pre-Seed round
30 September 2021· Thalwil, Switzerland· health, medical_diagnostics, biotech, software_hardware, b2b, remote_monitoring
Hemetron aims to transform chronic disease management with its remote blood testing platform, enabling patients to perform laboratory-grade blood tests at home, with results sent digitally to their physicians for timely treatment adjustments.
Investors
LeadDayOne Accelerator
Also participating
Venture KickETH ZurichSwiss-Israel Lean Launchpad
About Hemetron
Stage
Pre-Seed
Headquarters
Thalwil, Switzerland
Founded
2021
Team Size
6–20
Sectors
healthmedical_diagnosticsbiotechsoftware_hardwareb2bremote_monitoring